We are live on ! Find out more
ARGS

Argos Therapeutics
ARGS

Delisted

ARGS was delisted on the 24th of April, 2018.

21 hedge funds and large institutions have $31.8M invested in Argos Therapeutics in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.98% less ownership

Funds ownership: 23.38% → 22.4% (-0.98%)

16% less funds holding

Funds holding: 25 → 21 (-4)

38% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 8

87% less capital inflows, than outflows

Capital inflows: $135K | Capital outflows: $1.02M

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
5
Reduced
8
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

ARGS Hedge Fund Activity: Q2 2015 in Review

21 of the 3,729 institutional investors tracked by Wall St. Rank reported a position in Argos Therapeutics (ARGS) for Q2 2015, worth a combined $31.8M — down 22% from $41M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of ARGS and 0 opened new positions — a net loss of 5 holders — while 8 trimmed existing stakes and 5 added.

The largest buyer was StoneRidge PMG Advisors, LLC, adding an estimated $64.2K. The largest seller was HighTower Advisors, exiting entirely with an estimated $263K sold.

  • 21 institutional investors held Argos Therapeutics (ARGS) as of Q2 2015, down from 25 in Q1 2015.
  • Funds reported $31.8M of Argos Therapeutics stock for Q2 2015, down 22% quarter-over-quarter.
  • 0 funds opened new Argos Therapeutics positions in Q2 2015 and 5 closed out, a net change of -5 holders.
  • The largest Argos Therapeutics buyer in Q2 2015 was StoneRidge PMG Advisors, LLC, an estimated $64.2K added.
  • The largest Argos Therapeutics seller in Q2 2015 was HighTower Advisors, an estimated $263K sold.

Based on aggregated 13F filings for Q2 2015.